Showing results (151-160 of 168) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012Maha Hussain, Stephanie Daignault-Newton, Przemyslaw W Twardowski, et al.Nature Communications|August 29, 2023
Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistanceReyaz Ur Rasool, Caitlin M O'Connor, Chandan Kanta Das, et al.JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.JAMA Oncology|April 18, 2024
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate CancerJeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, et al.Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.Science Translational Medicine|August 5, 2011
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSAScott A Tomlins, Sheila M J Aubin, Javed Siddiqui, et al.Nature Medicine|June 8, 2010
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaNallasivam Palanisamy, Bushra Ateeq, Shanker Kalyana-Sundaram, et al.Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.Pageof 17